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Scarlet Fever Associated with Hepatitis –
A Report of Two Cases
M. Girisch, U. Heininger
Summary
Infection with group A beta-hemolytic streptococci
(GABHS) is the most common bacterial cause of acute
pharyngitis and tonsillitis beyond infancy. We report on
two patients with scarlet fever associated with hepatitis.
The patients (boys aged 6 and 7 years) both presented
with a scarlatiniform rash, dark urine and light-colored
stools. Laboratory studies revealed elevated liver
transaminases and negative antibody tests against
hepatitis viruses A, B and C, cytomegalovirus and
Epstein-Barr virus. Both patients were treated with
antibiotics and recovered completely within a few days.
Although the association between scarlet fever and
hepatitis has been known for many decades, the
pathogenesis is still unknown. Physicians treating
patients with group A beta-hemolytic streptococcal
infections should be aware of possible hepatic
involvement.
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Introduction
Infection with group A beta-hemolytic streptococci
(GABHS) is the most common bacterial cause of acute
pharyngitis and tonsillitis beyond infancy.Furthermore,eryth-
rogenic toxin-producing GABHS strains can cause scar-
let fever, which is characterized by a fine red rash, a swollen
red tongue (strawberry tongue) and desquamation of the
skin on the trunk, face and fingertips during convalescence.
In addition, a variety of other manifestations caused by
GABHS infection – including otitis media, sinusitis, mas-
toiditis, pneumonia, empyema, omphalitis, osteomyelitis,
streptococcal toxic shock syndrome and meningitis –  have
been reported [1]. Although hepatitis has previously been
described in association with scarlet fever and other
GABHS infections in children and adults, most of these re-
ports are not recent and are not mentioned in standard pe-
diatric or pediatric infectious disease textbooks [2–8]. We
would therefore like to report on two patients who recently
presented with this manifestation.
Case Reports
Case 1
A 6-year-old boy who had suffered typical scarlet fever for 5 days
was admitted to our hospital because of abdominal pain and sono-
graphically diagnosed enlargement of the gall bladder. On exam-
ination, he presented with a typical scarlatiniform rash (most
prominent in the genital region), sore red throat and enlarged cer-
vical lymph nodes without other abnormal findings. The boy was
afebrile. Remarkably, the urine was dark and the stools were light-
colored but there was no jaundice. Laboratory tests on admission
revealed elevated transaminases in serum (GOT 30 U/l, GPT
110 U/l, GGT 78 U/l, normal values: all < 20 U/l), and a mildly
elevated bilirubin of 1.8 mg/dl.Alkaline phosphatase (511 U/l) and
LDH (285 U/l) were in the upper normal range (110–600 U/l and
< 280 U/l, respectively).A full blood count was also within the nor-
mal range; C-reactive protein (CRP) in serum was < 0.3 mg/dl.
Serum assays for IgM and IgG antibodies against hepatitis viruses
A, B and C, cytomegalovirus and Epstein-Barr virus were all neg-
ative. The antistreptolysin test (ASL) was elevated at 600 IU/ml.
Since the patient had already been on erythromycin for 5 days, a
throat swab for culture was not performed. However, a GABHS
antigen test was positive. Since symptoms of scarlet fever had al-
ready improved, antibiotic therapy was left unchanged and con-
tinued for a further 9 days. The patient recovered completely
within 6 days and was discharged. On discharge, ultrasound ex-
aminations of the liver and gallbladder were unremarkable, GOT
was 26 U/l, GPT 58 U/l, GGT 45 U/l and bilirubin was 0.8 mg/dl.
Desquamation of the skin had appeared in the genital region. Five
months later ASL was 100 IU/ml.
Case 2
A 7-year-old boy was acutely ill with scarlet fever when he pre-
sented at the hospital. He had a previous history of surgery for
coarctation of the aorta and implantation of a ventriculo-peri-
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toneal shunt following hypoxic brain damage and development of
a hydrocephalus.There was no obvious epidemiological link to pa-
tient 1 who had been in our hospital 3 months previously.The boy
had been on penicillin for 4 days, he was still febrile (40 °C) and
his general condition was poor.As in patient 1, there was pharyn-
gitis, a scarlatiniform rash, dark urine and light-colored loose
stools. On admission, CRP was 23 mg/dl and the white blood count
was 9,200/µl with 81% neutrophils. Platelets were 198,000/µl.
Serum liver enzymes were elevated (GOT 91 U/l, GPT 133 U/l,
GGT 238 U/l) and bilirubin in serum was 2.7 mg/dl with 0.6 mg/dl
of conjugated bilirubin.Alkaline phosphatase (493 U/l) and LDH
(186 U/l) were within normal ranges. Serum assays for IgM and
IgG antibodies against hepatitis viruses A, B and C, cytomegalo-
virus and Epstein-Barr virus were all negative except for presence
of IgG antibodies against CMV.Analysis of CSF including culture
was normal. A throat culture revealed growth of GABHS. For an
initially suspected sepsis he was put on iv cefotaxim and van-
comycin. The boy recovered quickly and was discharged after
10 days. On discharge,ASL was elevated at 400 IU/ml, GOT, GPT
and bilirubin serum values had decreased (23 U/l, 41 U/l and
0.9 mg/dl, respectively) and were within the normal range 4 weeks
later. GGT and alakaline phosphatase had reached their maxima
on day 7 of hospital treatment (891 U/l and 1,577 U/l, respectively)
and were also within the normal range upon control 4 weeks later.
Discussion
We saw two patients with a clinical diagnosis of scarlet fever
and supportive laboratory evidence of GABHS infection
who both experienced liver involvement during the course
of their illness. Patient 1 had been on erythromycin for
5 days when symptoms of hepatitis started. Since eryth-
romycin, like other macrolide antibiotics, is known to cause
hepatic disturbances, one could argue that the patient's
symptoms might have been drug-related. However, hepati-
tis caused by erythromycin is ususally more pronounced
and does not resolve before the drug is discontinued [9, 10].
In our patient hepatitis had already regressed several days
before erythromycin therapy was stopped.
Hepatitis during scarlet fever was first reviewed by
MacMahon and Mallory in 1931 [5]. Since then, only a few
reports on this association in children and adults have been
published. Kocak et al. [4] observed two Turkish girls with
symptoms of hepatitis including jaundice which started a
few days after onset of scarlet fever and which was of re-
markably short duration (7 and 12 days, respectively). A
needle biopsy of the liver in one of the girls revealed poly-
morphonuclear granulocytes infiltrating the portal area and
degenerative changes in the hepatocytes. Similarly, a 29-
year-old woman and three young adults (aged 18 to
36 years) developed hepatitis within a few days of the onset
of scarlet fever [2, 3]. Furthermore, two adults (aged 22 and
62 years) were reported with severe kidney and liver in-
volvement during streptococcal scarlet fever [6]. Liver biop-
sies from these two patients revealed edema of the portal
spaces with infiltrates of lymphocytes, plasmocytes and
polymorphonuclears and necrosis of hepatocytes. In a 68-
year-old woman who developed post-streptococcal reactive
arthritis and transient hepatitis, liver biopsy revealed severe
inflammation and piecemeal necrosis [7]. In this report, 4/24
(17%) patients with post-streptococcal reactive arthritis de-
veloped mild, transient hepatitis. In addition, mild and
evanescent abnormalities in liver function tests were seen
in 25/39 patients with acute rheumatic fever and antecedent
streptococcal infection [8]. The mild clinical course in our
two patients did not justify liver biopsy.
In contrast to these reports, which clearly attribute he-
patitis as a complication to scarlet fever and other strepto-
coccal infections, one group suggested the opposite, namely
that scarlatiniform eruption may be associated with viral
hepatitis [11]. However, the findings in their case report
(scarlatiniform skin eruption 6 days before darkening of
urine, mild elevation of liver transaminases and no proven
viral etiology of hepatitis) are more indicative of hepatic in-
volvement in scarlet fever.
Hepatitis has also been found in patients with invasive
GABHS infections. In a series reported from Canada, 15/24
(63%) patients (comprising children and adults) with se-
vere invasive GABHS infection had elevated liver transam-
inases indicative of hepatic involvement [12]. However, no
further details on these patients were given. Furthermore,
hepatitis was found as a major complication in children with
meningitis caused by GABHS infection [13].
Taken together, all cases of hepatitis in association with
GABHS reported so far occurred in close temporal rela-
tionship with scarlet fever (frequently several days after on-
set of the skin rash) with other streptococcal infections
(acute rheumatic fever, post-streptococcal arthritis) or with
invasive infections. Many of these patients demonstrated
jaundice, while some were subicteric and therefore hepati-
tis may frequently be overlooked in patients with scarlet
fever. The pathogenesis of liver involvement under these
circumstances is unclear. Theoretically, direct toxic tissue
injury as well as immunological mechanisms may play a
role. Among an autopsy series of 59 cases of scarlet fever,
jaundice was found in four [14]. Post-mortem cultures of
blood and lungs yielded beta-hemolytic streptococci while
those of liver tissue did not, thus there is lack of evidence
of direct bacterial liver tissue damage. One could still argue
for a hepatotoxic effect caused by streptococcal pyrogenic
exotoxins which have been shown to induce cell damage via
direct influence on lymphokines, e.g. tumor necrosis factor
[15].
The frequency of hepatitis in children with scarlet fever
is unknown but appears to be rare. Physicians treating pa-
tients with scarlet fever and invasive GABHS infections
should be aware of the association.
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